
Michael Weinstein Upgraded (ABT) to Buy on, Jan 2nd, 2018
Michael Weinstein of JP Morgan, Upgraded "Abbott Laboratories" (ABT) to Buy on, Jan 2nd, 2018.
Michael has made no other calls on ABT in the last 4 months.
There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017
These are the ratings of the 2 analyists that currently disagree with Michael
- Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
- Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017
Contributing Sources
Similar Stocks and Investing Articles
[ Tue, Dec 12th 2017
] - WOPRAI
[ Thu, Oct 26th 2017
] - WOPRAI
[ Thu, Oct 26th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Aug 17th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Fri, Mar 01st 2013
] - WOPRAI
[ Fri, Jan 04th 2013
] - WOPRAI